Send mail to Author

A novel 2-metagene signature to identify high-risk HNSCC patients amongst those who are clinically at intermediate risk and are treated with PORT (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _  _    __   __    ______     ___     _    _      ___    
 | \| ||  \ \\/ //  /_   _//   / _ \\  | || | ||   / _ \\  
 |  ' ||   \ ` //     | ||    / //\ \\ | || | ||  | / \ || 
 | .  ||    | ||     _| ||   |  ___  ||| \\_/ ||  | \_/ || 
 |_|\_||    |_||    /__//    |_||  |_|| \____//    \___//  
 `-` -`     `-`'    `--`     `-`   `-`   `---`     `---`
 


Back to frontdoor view

OPUS4 Logo